Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative.[2] It was developed by Aktiebolaget Pharmacia in the 1950s.[3][failed verification]

Vinylbital
Clinical data
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
  • 5-(1-methylbutyl)-5-vinylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.017.633 Edit this at Wikidata
Chemical and physical data
FormulaC11H16N2O3
Molar mass224.260 g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(\C=C)C(C)CCC
  • InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h5,7H,2,4,6H2,1,3H3,(H2,12,13,14,15,16) checkY
  • Key:KGKJZEKQJQQOTD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Breimer DD, de Boer AG (1976). "Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration". Arzneimittel-Forschung. 26 (3): 448–54. PMID 989344.
  3. ^ US 2868790, Brandstrom AE, "Manufacture of Barbituric Acid Compounds", issued 13 January 1959, assigned to Pharmacia